News & Articles

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

UN3373 compliant sample packaging solution

Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Dr. John Wilson explains how ProtiFi set out to develop solutions to all the problems preventing omics from delivering real clinical impact

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days

The launch extends the Polar BioPharma Lifecycle Management (BPLM) platform with best practices in preclinical drug qualification

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

Protein Metrics’ software solutions complement Thermo Fisher’s mass spectrometry systems to facilitate precise, reliable data processing and drive innovation

The monthly safety report will be made public on the European Medicines Agency website

The first 510(K)-cleared transport medium for COVID-19 testing

Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location

The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails